Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer

被引：3
|
作者：
Costantini, Adrien
Cadranel, Jacques
机构：
[1] Tenon Hosp, Chest Dept, Paris, France
[2] Pierre & Marie Curie Univ, AP HP, GRC Theranoscan 04, Paris, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
10.1016/j.jtho.2017.11.113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E55 / E56
页数：2
相关论文
共 50 条
  • [1] Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Park, Song Ee
    Lee, Se Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 106 - 111
  • [2] Increased Antitumor Response to Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Park, S. E.
    Kim, Y.
    Kim, H. K.
    Lee, H.
    Cho, J. H.
    Lim, S. W.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    Sun, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [3] Response to Costantini et al. "Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer"
    Sun, Jong-Mu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : E56 - E57
  • [4] Response to Salvage Chemotherapy Following Exposure to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Leger, Paul
    Castellanos, Emily
    Pillai, Rathi
    Horn, Leora
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S918 - S919
  • [5] PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient
    Yu, Zhuo
    Zhang, Peiqing
    Gu, Weikuan
    Jiang, Xicheng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (08) : 2941 - 2943
  • [6] Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
    Shien, Kazuhiko
    Papadimitrakopoulou, Vassiliki A.
    Wistuba, Ignacio I.
    [J]. LUNG CANCER, 2016, 99 : 79 - 87
  • [7] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
    Li, Li
    Xu, Chunhua
    Wang, Wei
    Zhang, Qian
    [J]. CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [8] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [9] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    [J]. Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [10] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    [J]. CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
12345